ZARS Pharma and Duff & Phelps are both expected to price this week. If successful, they would be only the second and third PE-backed IPOs to price in September, following Athenahealth. The first week of October should be busier, with the following companies on tap: BioHeart, Merrion Pharmaceuticals, Constant Contact, MAP Pharmaceuticals and China Digital TV Holding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.